Clinical trials have demonstrated substantial efficacy, with patients achieving A1c reductions of 1.9% to 2.4% in type 2 diabetes and weight loss averaging 15% to 21% of baseline body weight after 72 weeks in adults without diabetes (more modest in those with type 2 diabetes)
Fiber is Your Essential Ally on the GLP-1 Weight Loss Journey When you begin treatment with GLP-1 medications like Wegovy, Zepbound, Ozempic, or Mounjaro, much of the focus is on what foods to avoid and how to manage side effects
Key players in the market include Novo Nordisk, Eli Lilly, Sanofi, Boehringer Ingelheim, AstraZeneca, Merck & Co., Bristol-Myers Squibb, and Amgen
It's something I enjoy
Attaching a new needle correctly and performing a flow check with each new pen ensures a proper dose
Le GLP1 ne fait pas exception